Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer
In developed countries, lung cancer is the leading cause of cancer-related death in both sexes. Although cigarette smoking represents the principal risk factor for lung cancer in females, the higher proportion of this neoplasm among non-smoking women as compared with non-smoking men implies distinct...
Guardado en:
Autores principales: | Tiziana Vavalà, Annamaria Catino, Pamela Pizzutilo, Vito Longo, Domenico Galetta |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90b2b3106607485ea016497f23d99f64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
por: Chuan HUANG, et al.
Publicado: (2021) -
Role of afatinib in the treatment of advanced lung squamous cell carcinoma
por: Vavalà T
Publicado: (2017) -
Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Damian Mojsak, et al.
Publicado: (2021) -
Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening
por: Tao Yan, et al.
Publicado: (2021) -
Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury
por: Zengfu Zhang, et al.
Publicado: (2021)